Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
The Journal of Biological Chemistry
|
April 11, 2003
A transmembrane segment mimic derived from Escherichia coli diacylglycerol kinase inhibits protein activity
Anthony W Partridge, Roman A Melnyk, Dawn Yang, et al.
The Journal of Chemical Physics
|
February 16, 2022
Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides
Jianguo Li, Srinivasaraghavan Kannan, Pietro Aronica, et al.
Biopolymers
|
March 3, 2004
Polar residue tagging of transmembrane peptides
Roman A Melnyk, Anthony W Partridge, Jeannie Yip, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2021
Rapid Evaluation of Small Molecule Cellular Target Engagement with a Luminescent Thermal Shift Assay
Jonathan D Mortison, Ivan Cornella-Taracido, Gireedhar Venkatchalam, et al.
The Journal of Biological Chemistry
|
November 13, 2004
Destabilization of the transmembrane domain induces misfolding in a phenotypic mutant of cystic fibrosis transmembrane conductance regulator
Mei Y Choi, Anthony W Partridge, Craig Daniels, et al.
Biochemistry
|
October 6, 2007
Transmembrane domain of myelin protein zero can form dimers: possible implications for myelin construction
Megan L Plotkowski, Sanguk Kim, Martin L Phillips, et al.
Journal of Molecular Biology
|
June 8, 2006
Self-association of the transmembrane domain of an anthrax toxin receptor
Mandy Y Go, Sanguk Kim, Anthony W Partridge, et al.
The Journal of Clinical Investigation
|
July 14, 2007
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation
Brian G Petrich, Per Fogelstrand, Anthony W Partridge, et al.
Cell
|
January 16, 2007
Structural basis of integrin activation by talin
Kate L Wegener, Anthony W Partridge, Jaewon Han, et al.
Iscience
|
May 24, 2024
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors
Katrine Ingelshed, Marit M Melssen, Pavitra Kannan, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
The Journal of Biological Chemistry
|
April 11, 2003
A transmembrane segment mimic derived from Escherichia coli diacylglycerol kinase inhibits protein activity
Anthony W Partridge, Roman A Melnyk, Dawn Yang, et al.
The Journal of Chemical Physics
|
February 16, 2022
Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides
Jianguo Li, Srinivasaraghavan Kannan, Pietro Aronica, et al.
Biopolymers
|
March 3, 2004
Polar residue tagging of transmembrane peptides
Roman A Melnyk, Anthony W Partridge, Jeannie Yip, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2021
Rapid Evaluation of Small Molecule Cellular Target Engagement with a Luminescent Thermal Shift Assay
Jonathan D Mortison, Ivan Cornella-Taracido, Gireedhar Venkatchalam, et al.
The Journal of Biological Chemistry
|
November 13, 2004
Destabilization of the transmembrane domain induces misfolding in a phenotypic mutant of cystic fibrosis transmembrane conductance regulator
Mei Y Choi, Anthony W Partridge, Craig Daniels, et al.
Biochemistry
|
October 6, 2007
Transmembrane domain of myelin protein zero can form dimers: possible implications for myelin construction
Megan L Plotkowski, Sanguk Kim, Martin L Phillips, et al.
Journal of Molecular Biology
|
June 8, 2006
Self-association of the transmembrane domain of an anthrax toxin receptor
Mandy Y Go, Sanguk Kim, Anthony W Partridge, et al.
The Journal of Clinical Investigation
|
July 14, 2007
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation
Brian G Petrich, Per Fogelstrand, Anthony W Partridge, et al.
Cell
|
January 16, 2007
Structural basis of integrin activation by talin
Kate L Wegener, Anthony W Partridge, Jaewon Han, et al.
Iscience
|
May 24, 2024
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors
Katrine Ingelshed, Marit M Melssen, Pavitra Kannan, et al.
Page
of 4